EPI Prevalence and Risk Factors in Chronic Pancreatitis: A Meta-Analysis

Exocrine Pancreatic Insufficiency Affects 40% of Chronic Pancreatitis Patients, Study Reveals

• 40% of chronic pancreatitis patients experience EPI, with diagnostic methods heavily influencing prevalence estimates.
• Smoking increases EPI risk by 51%, highlighting the importance of cessation programs.
• Fecal elastase-1 testing detected EPI in 52.1% of cases, compared to 21.1% with fecal fat testing.

Diagnostic Variability and Clinical Implications

The meta-analysis, led by Xinying Tang and colleagues, revealed stark disparities in EPI prevalence depending on diagnostic methods. Fecal elastase-1 (FE-1) testing, which detects mild to moderate exocrine dysfunction, yielded the highest prevalence at 52.1% (95% CI, 44.2% to 59.9%). In contrast, fecal fat testing identified EPI in only 21.1% of cases, reflecting its focus on overt malabsorption. These differences highlight the limitations of current diagnostic practices, as noted by the authors: “A lack of standardized protocols compromises the consistency of findings across cohorts.”

Regional variations in prevalence were observed but not statistically significant. Asia reported 31.3%, Europe 44.5%, and North America 39.8%.

Smoking as a Key Risk Factor

Pooled data from four studies confirmed a significant association between smoking and EPI in chronic pancreatitis patients (OR, 1.51; 95% CI, 1.25 to 1.76). The findings align with broader public health efforts to address tobacco use as a modifiable risk factor.

Additional risk factors identified in individual studies included low body mass index and male sex (HR, 1.84). Pancreatic resection, bile duct stenosis, and diabetes also showed associations, though these findings require validation in larger cohorts. The study’s authors noted that disease duration—a likely confounder—was inconsistently reported across datasets, complicating causal inferences.

Challenges in Standardizing EPI Screening

The high heterogeneity (I² = 96.7%) in pooled prevalence estimates shows how complex diagnosing EPI is. FE-1 cutoffs varied between 100 μg/g and 200 μg/g, with some studies reporting false positives in patients with watery diarrhea.

The study also found that EPI prevalence in painless chronic pancreatitis was 47.6%, though comparisons with painful CP were not possible due to limited data. This gap in understanding emphasizes the need for longitudinal studies to clarify the relationship between pain and exocrine dysfunction.

Future Directions and Research Priorities

The study’s findings call for immediate action to harmonize EPI screening practices. “A lack of standardized diagnostic protocols for EPI in current CP studies substantially compromises the consistency and comparability of findings across cohorts,” wrote Tang and colleagues.

As research progresses, the focus will shift to refining risk stratification models and developing targeted interventions. For patients, early detection through consistent screening remains critical. For providers, adopting evidence-based practices will be key to addressing this underappreciated complication of chronic pancreatitis.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.